1. Home
  2. FNA vs BXC Comparison

FNA vs BXC Comparison

Compare FNA & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNA
  • BXC
  • Stock Information
  • Founded
  • FNA 2010
  • BXC 2004
  • Country
  • FNA United States
  • BXC United States
  • Employees
  • FNA N/A
  • BXC N/A
  • Industry
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BXC Wholesale Distributors
  • Sector
  • FNA Health Care
  • BXC Consumer Discretionary
  • Exchange
  • FNA Nasdaq
  • BXC Nasdaq
  • Market Cap
  • FNA 910.9M
  • BXC 869.2M
  • IPO Year
  • FNA 2021
  • BXC 2004
  • Fundamental
  • Price
  • FNA $10.89
  • BXC $106.65
  • Analyst Decision
  • FNA Strong Buy
  • BXC Strong Buy
  • Analyst Count
  • FNA 5
  • BXC 3
  • Target Price
  • FNA $15.60
  • BXC $135.67
  • AVG Volume (30 Days)
  • FNA 533.4K
  • BXC 60.0K
  • Earning Date
  • FNA 02-27-2025
  • BXC 02-18-2025
  • Dividend Yield
  • FNA N/A
  • BXC N/A
  • EPS Growth
  • FNA N/A
  • BXC N/A
  • EPS
  • FNA N/A
  • BXC 3.41
  • Revenue
  • FNA $244,995,000.00
  • BXC $2,954,424,000.00
  • Revenue This Year
  • FNA $18.58
  • BXC N/A
  • Revenue Next Year
  • FNA $14.85
  • BXC $4.71
  • P/E Ratio
  • FNA N/A
  • BXC $31.32
  • Revenue Growth
  • FNA 18.16
  • BXC N/A
  • 52 Week Low
  • FNA $4.65
  • BXC $87.67
  • 52 Week High
  • FNA $14.79
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • FNA 60.29
  • BXC 48.33
  • Support Level
  • FNA $10.11
  • BXC $105.68
  • Resistance Level
  • FNA $11.10
  • BXC $109.36
  • Average True Range (ATR)
  • FNA 0.61
  • BXC 4.04
  • MACD
  • FNA -0.04
  • BXC 1.24
  • Stochastic Oscillator
  • FNA 84.80
  • BXC 82.52

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: